Erratum: Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone (Journal of Cellular Biochemistry (2003) 89 (1154-1163) DOI: 10.1002/jcb.10578));Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone

Journal of Cellular Biochemistry

Volumn 89, Issue 6, 2003, Pages 1154-1163

  Si, Andrew I C ^b   Huang, Lin ^b   Xu, Jiake ^a   Kumta, Shekhar M ^b   Wood, David ^a   Zheng, Ming H ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

EMMPRIN; Giant cell tumor (GCT) of bone; MMPs; RANKL; TIMPs

Indexed keywords

CD147 ANTIGEN; MATRIX METALLOPROTEINASE; OSTEOCLAST DIFFERENTIATION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BONE CANCER; BONE TUMOR; CANCER INVASION; CANCER STAGING; CELL DIFFERENTIATION; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GIANT CELL TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGE; METASTASIS; MONOCYTE; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STROMA CELL; TUMOR GROWTH;

EID: 0042570772     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24256     Document Type: Erratum

References (51)

1. Atkins GJ, Haynes DR, Graves SE, Evdokiou A, hay S, Bouralexis S, Findlay DM. 2000. Expression of osteoclast differentiation signals by stromal elements of giant cell tumors. J Bone Miner Res 15:640-649.
2. Berditchevski F, Chang S, Bodorova J, Hemler ME. 1997. Generation of monoclonal antibodies to integrin-associated proteins. Evidence that alpha3beta1 complexes with EMMPRIN/basigin/OX47/M6. J Biol Chem 272:29174-29180.
3. Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H, Nabeshima K. 1995. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 55:434-439.
4. Bordador LC, Li X, Toole B, Chen B, Regezi J, Zardi L, Hu Y, Ramos DM. 2000. Expression of emmprin by oral squamous cell carcinoma. Int J Cancer 85:347-352.
5. Caudroy S, Polette M, Tournier JM, Burlet H, Toole B, Zucker S, Birembaut P. 1999. Expression of the extracellular matrix metalloproteinase inducer (EMMPRIN) and the matrix metalloproteinase-2 in bronchopulmonary and breast lesions. J Histochem Cytochem 47: 1575-1580.
6. Dalberg K, Eriksson E, et al. 2000. Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: Correlation with invasive growth of breast cancer. World J Surg 24:334-340.
7. DeCastro R, Zhang Y, Guo H, Kataoka H, Gordon MK, Toole BP. 1996. Human keratinocytes express EMMPRIN, an extracellular matrix metalloproteinase inducer. J Invest Dermatol 106:1260-1265.
8. Dorfman DH, Czeriniak B. 1998. Giant cell tumors of bone in bone tumours. Mosby Publisher, p 559-606.
9. Doussis I, Puddle AB. 1992. Immunophenotype of multinucleated and mononuclear cells in giant cell lesions of bone and soft tissue. J Clin Pathol 45:398-404.
10. Ellis SM, Nabeshima K, Biswas C. 1989. Monoclonal antibody preparation and purification of a tumor cell collagenase-stimulatory factor. Cancer Res 49:3385-3391.
11. Enneking WF. 1983. Staging benign lesions. In: Enneking WF, editor. Musculoskeletal tumour surgery. Vol. 1, New York; Churchill Livingstone.
12. Gamberi G, Benassi MS, Bohling T, Ragazzini P, Molendini L, Sollazzo MR, Merli M, Ferrari C, Magagnoli G, Bertoni F, Picci P. 1998. Prognostic relevance of C-myc gene expression in giant-cell tumor of bone. J Orthop Res 16:1-7.
13. Goldring SR, Roelke MS, Petrison KK, Bhan AK. 1987. Human giant cell tumors of bone - Identification and characterization of cell types. J Clin Invest 79:483-491.
14. Guo H, Zucker S, Gordon MK, Toole BP, Biswas C. 1997. Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J Biol Chem 272:24-27.
15. Hart IR, Saini A. 1992. Biology of tumour metastasis. Lancet 339:1453-1457.
16. Huang L, Xu J, Wood DJ, Zheng MH. 2000. Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: Possible involvement in tumor cell-induced osteoclast-like cell formation. Am J Pathol 156:761-767.
17. Joronen K, Salminen H, Glumoff V, Savontaus M, Vuorio E. 2000. Temporospatial expression of tissue inhibitors of matrix metalloproteinases-1, -2 and -3 during development, growth and aging of the mouse skeleton. Histochem Cell Biol 114:151-165.
18. Kanekura T, Chen X, et al. 2002. Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int J Cancer 99:520-528.
19. Kataoka H; DeCastro R, Zucker S, Biswas C. 1993. Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase. Cancer Res 53:3154-3158.
20. Kleiner DE, Stetler-Stevenson WG. 1999. Matrix metalloproteinase and metastasis. Cancer Chemother Pharmacol 43:42-51.
21. Liang L, Major T, Bocan T. 2002. Characterization of the promoter of human extracellular matrix metalloproteinase inducer (EMMPRIN). Gene 282:75-86.
22. Lim M, Martinez T, Jablons D, Cameron R, Guo H, Toole BP, Li JD, Basbaum C. 1998. Tumor-derived EMMPRIN stimulates collagenase transcription through MAPK pg38. FEBS Lett 441:88-92.
23. Liotta LA, Steeg PS, Stetler Stevenson WG. 1991. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64:327-336.
24. MacDougall JR, Matrisian LM. 1995. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev 14:351-362.
25. Major TC, Liang L, Lu X, Roebury W, Bocan TM. 2002. Extra cellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma. Arterioscler Throm Vasc Biol 122:200-207
26. Marmorstein AD, Bonilha VL, Chiflet S, Neill JM, Rodriguez-Boulan E. 1996. The polarity of the plasma membrane protein RET-PE2 in retinal pigment epithelium is developmentally regulated. J Cell Sci 109:3025-3034.
27. Masui F, Ushigome S, et al. 1998. Giant cell tumor of bone: An immunohistochemical comparative study. Pathol Int 48:355-361.
28. McCarthy EF, Frassica FJ. 1998. Giant cell tumors of bone in pathology of bone and joint disorders with clinical and radiographic correlation. WB Sauders 252-253.
29. Muraoka K, Nabeshima K, Murayama T, Biswas C, Koono M. 1993. Enhanced expression of a tumor-cell-derived collagenase-stimulatory factor in urothelial carcinoma: Its usefulness as a tumor marker for bladder cancers. Int J Cancer 55:19-26.
30. Nabeshima K, Lane WS, Biswas C. 1991. Partial sequencing and characterization of the tumor cell-derived collagenase stimulatory factor. Arch Biochem Biophys 285:90-96.
31. Oda Y, Sakamoto A, et al. 2001. Secondary malignant giant-cell tumour of bone: Molecular abnormalities of p53 and H-ras gene correlated with malignant transformation. Histopathology 39:629-637.
32. Rao VH, Bridge JA, Neff JR, Schaefer GB, Buehler BA, Vishwanatha JK, Pollock RE, Nicolson GL, Yamamoto M, Gokaslam ZL, et al. 1995. Expression of 72 kDa and 92 kDa type IV collagenases from human giant-cell tumor of bone. Clin Exp Metastasis 13:420-426.
33. Rao VH, Singh RK, Bridge JA, Neff JR, Schaefer GB, Delimont DC, Dunn CM, Sanger WG, Buehler BA, Sawaya R, Nicolson GL, Rao JS. 1997. Regulation of MMP-9 (92 kDa type IV collagenase/gelatinase B) expression in stromal cells of human giant cell tumor of bone. Clin Exp Metastasis 15:400-409.
34. Sameshima T, Nabeshima K. 2000. Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas. Int J Cancer 88:21-27.
35. Sasaguri Y, Komiya S, Sugama K, Suzuki K, Inoue A, Morimatsu M, Nagase H. 1992. Production of matrix metalloproteinases 2 and 3 (stromelysin) by stromal cells of giant cell tumor of bone. Am J Pathol 141:611-621.
36. Schajowicz F. 1994. Tumors and tumor-like lesions of bone - Pathology, radiology and treatment. 2nd edition, Berlin; Springer-Verlag, p 257-295.
37. Sun J, Hemler ME. 2001. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. Cancer Res 61:2276-2281.
38. Taylor PM, Woodfield RJ, et al. 2002. Breast cancer cell-derived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A(2) and 5-lipoxygenase catalyzed pathway. Oncogene 21:5765-5772.
39. Teti A, Farina AR, Villanova I, Tiberio A, Tacconelli A, Sciortino G, Chambers AF, Gulino A, Mackay AR. 1998. Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin, bone ialoprotein and GRGDSP peptides is RGD and cell shape change dependent. Int J Cancer 77:82-93.
40. Tomita T, Nakase T, et al. 2002. Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum 46:373-378.
41. Ueda Y, Imai K, Tsuchiya H, Fujimoto N, Nakanishi I, Katsuda S, Seiki M, Okada Y. 1996. Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion. Am J Pathol 148: 611-622.
42. van den Oord JJ, Paemen L. 1997. Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin. Am J Pathol 151:665-670.
43. Xu J, Tan JW, Huang L, Gao XH, Laird R, Liu D, Wysocki S, Zheng MH. 2000. Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-kappaB ligand. J Bone Miner Res 15: 2178-2186.
44. Zheng MH, Fan Y. 1994. Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration. Am J Pathol 145:1095-1104.
45. Zheng MH, Xu J, et al. 2000. Gene expression of vascular endothelial growth factor in giant cell tumors of bone. Hum Pathol 31:804-812.
46. Zheng MH, Fan Y, Wysocki S, Wood DJ, Papadimitriou JM. 1993. Detection of mRNA for carbonic anhydrase II in human osteoclast-like cells by in situ hybridization. J Bone Miner Res 8:113-118.
47. Zheng MH, Fan Y, Panicker A, Smith A, Robertson T, Wysocki S, Robbins P, Papadimitriou JM, Wood DJ. 1995. Detection of mRNAs for urokinase-type plasminogen activator, its receptor, and type 1 inhibitor in giant cell tumors of bone with in situ hybridization. Am J Pathol 147:1559-1566.
48. Zheng MH, Fan Y, Smith A, Wysocki S, Papadimitriou JM, Wood DJ. 1998. Gene expression of monocyte chemoattractant protein-1 in giant cell tumors of bone osteoclastoma: Possible involvement in CD68+ macrophage-like cell migration. J Cell Biochem 70:121-129.
49. Zheng MH, Siu P, Papadimitriou JM, Wood DJ, Murch AR. 1999. Telomeric fusion is a major cytogenetic aberration of giant cell tumors of bone. Pathology 31: 373-378.
50. Zucker S, Biswas C. 1994. Tumor collagenase-stimulating factor: A paracrine stimulator of fibroblast production of matrix metalloproteinases in cancer. Bull Inst Pasteur 92:284-290.
51. Zucker S, Cao J, et al. 2000. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene 19:6642-6650.